ESC CCS Clinical Likelihood
Walks the diagnostic pathway of the 2024 ESC chronic coronary syndromes guideline: the Risk Factor-weighted Clinical Likelihood of obstructive CAD, adjustment for abnormal findings, coronary calcium reclassification, the recommended first-line test, and the post-test likelihood once a result is in.
Guideline — the ESC 2024 pathway only, with published likelihood ratios for the modalities it recommends.
Risk Factor-weighted Clinical Likelihood (RF-CL): sex, age, symptom score and number of risk factors.
ESC 2024 CCS · Figure 4
Complete step 1 to enable adjustment.
Complete step 1 to see the recommendation.
Complete step 1 to apply a test.
High-risk findings on the tests you recorded. Assessed independently of the likelihood above — a high event risk is its own indication for invasive angiography.
High > 3%/year cardiac mortality · intermediate 1–3% · low < 1%. An initial stratification on basic clinical assessment — age, ECG, anginal threshold, diabetes, CKD, LVEF — is recommended first (Class I B); the findings below identify high risk on the tests themselves.
Criteria appear here for each test as you record it — an EST in step 2, or any modality applied in step 4.
ESC 2024 CCS · Recommendation Table 14, Recommendation Table 11
Source: Vrints C, Andreotti F, Koskinas KC, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J 2024;45:3415–3537. Values are taken from Figures 4, 5, 6 and 8 and Recommendation Table 13. Where the guideline publishes no number, none is invented — the app says so instead.